Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Concentrix (CNXC) Gains from Investment Securities (2020 - 2025)

Concentrix's Gains from Investment Securities history spans 5 years, with the latest figure at -$6.2 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 77.67% year-over-year to -$6.2 million; the TTM value through Nov 2025 reached -$9.0 million, up 69.1%, while the annual FY2025 figure was -$2.0 million, 93.31% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$6.2 million at Concentrix, down from $4.8 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $20.1 million in Q3 2024 and bottomed at -$27.8 million in Q4 2024.
  • The 5-year median for Gains from Investment Securities is $711500.0 (2022), against an average of $355642.9.
  • The largest annual shift saw Gains from Investment Securities soared 8283.67% in 2023 before it plummeted 443.31% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $18.4 million in 2021, then tumbled by 92.81% to $1.3 million in 2022, then soared by 511.25% to $8.1 million in 2023, then tumbled by 443.31% to -$27.8 million in 2024, then surged by 77.67% to -$6.2 million in 2025.
  • Per Business Quant, the three most recent readings for CNXC's Gains from Investment Securities are -$6.2 million (Q4 2025), $4.8 million (Q3 2025), and -$27.8 million (Q4 2024).